Teijin Acquires Global Structure Database Management Licenses and Switches Over to JChem Platform

ChemAxon and Teijin Pharma Ltd. has announced the acquisition of ChemAxon's database structure management and search toolkits and the switch over of Teijin Pharma's chemical information platform to operate with ChemAxon's JChem technology.

The provision will see Teijin Pharma, a medical and pharmaceuticals business subsidiary of Teijin, update their existing system for archiving small molecules by implementing the JChem platform.

The adoption of the JChem platform for small molecule storage and search constitutes a step forward in this process.

"We are pleased with the performance and potential of the JChem tools in our system, the functions are particularly suitable for distributed, enterprise class solutions," commented Dr. Hiroshi Kawabata, Ph.D., Senior Manager, Medicinal Chemistry Research Department, Pharmaceutical Discovery Research Laboratories at Teijin Pharma Limited.

"We are very happy that our science and functionality is relevant to Teijin, particularly given its scale and scope," commented Dr Ferenc Csizmadia, CEO of ChemAxon.

"Commercially we believe that this switch may fully open the door for further adoptions in Japan and would mirror our experience with clients globally."